{
  "pmid": "20739364",
  "uid": "20739364",
  "title": "Should treatment for heart failure with preserved ejection fraction differ from that for heart failure with reduced ejection fraction?",
  "abstract": "",
  "authors": [
    {
      "last_name": "Jong",
      "fore_name": "Philip",
      "initials": "P",
      "name": "Philip Jong",
      "affiliations": [
        "Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Canada."
      ]
    },
    {
      "last_name": "McKelvie",
      "fore_name": "Robert",
      "initials": "R",
      "name": "Robert McKelvie",
      "affiliations": []
    },
    {
      "last_name": "Yusuf",
      "fore_name": "Salim",
      "initials": "S",
      "name": "Salim Yusuf",
      "affiliations": []
    }
  ],
  "journal": {
    "title": "BMJ (Clinical research ed.)",
    "iso_abbreviation": "BMJ",
    "issn": "1756-1833",
    "issn_type": "Electronic",
    "volume": "341",
    "pub_year": "2010",
    "pub_month": "Aug",
    "pub_day": "25"
  },
  "start_page": "c4202",
  "pages": "c4202",
  "language": "eng",
  "publication_types": [
    "Journal Article"
  ],
  "keywords": [
    "Adrenergic beta-Antagonists",
    "Angiotensin-Converting Enzyme Inhibitors",
    "Evidence-Based Medicine",
    "Heart Failure",
    "Humans",
    "Randomized Controlled Trials as Topic",
    "Stroke Volume",
    "Treatment Outcome"
  ],
  "article_ids": {
    "pubmed": "20739364",
    "doi": "10.1136/bmj.c4202",
    "pii": "bmj.c4202"
  },
  "doi": "10.1136/bmj.c4202",
  "dates": {
    "completed": "2010-09-23",
    "revised": "2024-12-19"
  },
  "chemicals": [
    "Adrenergic beta-Antagonists",
    "Angiotensin-Converting Enzyme Inhibitors"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "current_affiliation",
    "retrieved_date": "2025-07-30T15:11:57.585067",
    "pmid": "20739364"
  }
}